Variant report
Variant | esv2439458 |
---|---|
Chromosome Location | chr4:173424507-173435431 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3104245 | chr4:173434869-173434870 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs114653091 | chr4:173434920-173434921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528511118 | chr4:173434961-173434962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185741908 | chr4:173434986-173434987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568573465 | chr4:173434990-173434991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536412749 | chr4:173435005-173435006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs137867352 | chr4:173435030-173435031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569795292 | chr4:173435052-173435053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142357879 | chr4:173435056-173435057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538624 | chr4:173435062-173435063 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs145958094 | chr4:173435064-173435065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534338809 | chr4:173435093-173435094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs80169749 | chr4:173435113-173435114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112898490 | chr4:173435173-173435174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574203005 | chr4:173435243-173435244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543152190 | chr4:173435251-173435252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557509845 | chr4:173435276-173435277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189871412 | chr4:173435283-173435284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181624409 | chr4:173435323-173435324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367698071 | chr4:173435327-173435328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371656751 | chr4:173435346-173435347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559820293 | chr4:173435404-173435405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528450570 | chr4:173435405-173435406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542256074 | chr4:173435413-173435414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:173434800-173436000 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr4:173434800-173436600 | Enhancers | Hela-S3 | cervix |
3 | chr4:173434800-173437200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:173435000-173435800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |